Hepatic enzyme ALT as a marker of glucose abnormality in men with cystic fibrosis.

Hepatic enzyme ALT as a marker of glucose abnormality in men with cystic fibrosis.

<h4>Aim</h4>Cystic fibrosis (CF) patients are at high risk of developing CF-related diabetes (CFRD). In non-CF patients, liver disease, specifically steatosis and non-alcoholic fatty liver disease (NAFLD), is strongly associated with type 2 diabetes. We compared glycemic status and metab...

Full description

Bibliographic Details
Main Authors: Johann Colomba, Silvia R Netedu, Catherine Lehoux-Dubois, Adèle Coriati, Valérie Boudreau, François Tremblay, Kenneth Cusi, Rémi Rabasa-Lhoret, Julio A Leey
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2019-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0219855

Internet

https://doi.org/10.1371/journal.pone.0219855

Similar Items